genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Jakafi Success Helps Incyte Land Blockbuster MorphoSys Partnership
GEN Edge
Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
GEN Edge
From J.P. Morgan: Cell, Gene Therapy to Drive Biopharma M&A in…
GEN Edge
AGTC Plans Pivotal Trial for XLRP Gene Therapy
GEN Edge
TwinStrand’s Duplex Sequencing Goes Deep
News
News
Cells Huddle to Cope with Stress, Defy Cancer Meds
Commentary
Notes and Takeaways from JPM 2020
News
ELOVL2 Gene Found to Play Critical Role in Aging of the…
Genetics
Molecular Bridge Found for ALS Genes
Neuroscience
Decision Making Visualized in Zebrafish Larva, Points to Surprising Role for…
Insights
All
Trends for 2020
ALS
Neurodegenerative Treatments Build to a Tipping Point
Insights
Silencing Breast Cancer Genes Using Morpholino Embedded DNA-Tile-AuNPs Nanostructures
Insights
Learning to Speak Genome
Brexit
Ensuring the Security of Supply for Brexit
A-Lists
Insights
Top 10 Young Companies in the Money, 2019
January 2020 Vol. 40 No. 1
8 Biopharma Trends to Watch in 2020
Cancer
Top 10 Immuno-Oncology Startups of 2019
Drug Discovery
Top 10 Pharma Companies of 2019
December 2019 Vol. 39 No. 12
Top 25 Biotech Companies of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Cells Huddle to Cope with Stress, Defy Cancer Meds
Commentary
Notes and Takeaways from JPM 2020
News
ELOVL2 Gene Found to Play Critical Role in Aging of the…
ALS
Neurodegenerative Treatments Build to a Tipping Point
Magazine
Artificial Intelligence
The Outlook for 2020 and Beyond
January 2020 Vol. 40 No. 1
Super-Resolution Microscopy Comes into Focus
January 2020 Vol. 40 No. 1
Biopharma’s Lab of the Future Can’t Wait
January 2020 Vol. 40 No. 1
Convergence Fends Off Malthus
January 2020 Vol. 40 No. 1
From CRISPR Multiplexing to Pleistocene Park
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
Find the Right Fit when Tackling Late Stage Bioprocessing Challenges
Upcoming Webinars
Get Fired Up about Multiplexed Biomarker Profiling
Upcoming Webinars
Designing Next-Generation Regulatory T Cell Therapies with Single-Cell Proteomics
January 2020 Vol. 40 No. 1
Experimental Program Design Considerations for Optimized Use of Preclinical Models in…
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Sanofi
Sanofi
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Sanofi
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen Cancer Pipelines
Sanofi
Lexicon Fires Back after Sanofi Ends Up-to-$1.7B Diabetes Collaboration
Sanofi
Acer Therapeutics Axes 60% of Workforce after FDA Rebuff
Sanofi
Sanofi Cuts 466 Jobs, Limits Cardiovascular and Diabetes R&D
Sanofi
Sanofi, Google Launch “Innovation Lab” Aimed at Drug Discovery
Sanofi
Verily Joins Novartis, Otsuka, Pfizer, and Sanofi in Clinical Trial Alliance
Sanofi
FDA Approves Sanofi’s Dengue Prevention Vaccine Dengvaxia in Narrower Patient Population
Sanofi
Sanofi to Develop Biomunex Bi-, Multi-Specific Antibodies for Immuno-Oncology and Other...
Sanofi
To Treat Acute Cannabinoid Overdose, Opiant Looks to Reformulation of Drinabant
Sanofi
Opiant Pharmaceuticals to Develop Sanofi’s Acute Cannabinoid Overdose Candidate Drinabant
Sanofi
Sanofi, Denali Launch $1B+ Alliance to Develop RIPK1 Inhibitors for Neurological,...
Sanofi
Sanofi, Evotec Launch New “BRIDGE” Partnership to Accelerate Drug Discovery
Sanofi
Regulus Axing 60% of Workforce, Pauses Patient Recruitment for Lead Program
Sanofi
Sanofi Agrees to Transfer Infectious Disease Unit, 100 Employees to Evotec
Sanofi
Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; }
![Sanofi’s global vaccines unit Sanofi Pasteur has launched an up-to-$805 million partnership with Translate Bio to develop messenger RNA vaccines for up to five undisclosed infectious disease pathogens. [Ryan Jeffs/Wikicommons]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar14_2017_WikiCommons_MicroRNAAndmRNAVisualization2173942127-324x160.jpg "Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership")
